Down 57%, Is Nike Stock a Buy in 2026?

Nike's multi-year decline stems from a failed post‑COVID direct‑to‑consumer pivot and deteriorating demand in China: footwear sales in North America rose ~9% YoY to $3.54 billion in the fiscal second quarter while China footwear sales plunged 20% in the same quarter, marking six consecutive quarters of decline. The piece highlights structural brand erosion, counterfeit competition and overreliance on low‑cost manufacturing in China, notes a forward P/E of 38 versus an S&P 500 average of 22, and concludes that a sustained turnaround appears unlikely, recommending avoidance of the stock.

Analysis

Market structure: Nike (NKE) is the loser: China footwear sales -20% in the fiscal Q2 and six straight quarters of decline signal permanent share loss to domestic brands (e.g., ANTA). Winners include ANTA and Li‑Ning (domestic Chinese sportswear) and regional manufacturers in Southeast Asia if sourcing shifts; shelf-space ceded to rivals reduces Nike’s retail pricing power and raises promotional cadence, compressing gross margins by mid-single digits over 12–24 months. Cross-asset: expect higher equity implied vol on NKE (short-term), modest widening in consumer discretionary credit spreads, mild USD/CNY sensitivity (CNY weakness exacerbates perception risk), and limited commodity impact except polyester/ rubber cost pass-throughs to suppliers.

Risk assessment: Tail risks include aggressive China regulatory nationalism or tariffs, a faster-than-expected RMB depreciation (>5% in 3 months) that hits revenue translation, or an operational shock (major product recall) that accelerates brand erosion. Time horizons: immediate (days) = elevated IV around earnings; short-term (0–6 months) = continued China weakness and margin pressure; long-term (3–5 years) = potential brand recovery but only with sustained investment and market-share regains. Hidden dependencies: counterfeit quality diffusion and manufacturing footprint in China create structural brand risk; inventory cycles at wholesale channels can mask demand until 2–3 quarters later. Key catalysts: monthly China retail data, Nike’s next quarterly China comps, and any JV/localization announcements.

Trade implications: Direct: establish a 3–5% notional short NKE position or buy 6‑month put spreads (buy 1–2% notional 10–15% OTM, sell 20–25% OTM to finance) ahead of next quarter; fund with a 2–3% long in ANTA (H‑share/US ADR) as a relative-play. Pair trade: long ANTA (2–3% exposure) / short NKE (3–4%) to express China consumer rotation. Options: use a 3–6 month put‑spread on NKE to limit capital but capture downside; sell near-term covered calls on any existing NKE exposure to buy puts. Sector rotation: trim US athletic apparel exposure, reallocate 2–4% to Asia domestic sportswear and footwear suppliers. Entry/exit: scale in now, add on -10% NKE move, cover short if NKE rallies >12% from entry or forward P/E compresses to 25 with China sequential improvement over two quarters.

Contrarian angles: Consensus underestimates that North American footwear stabilized (+9% YoY in Q2) and that inventory normalization could produce a 6–12 month bounce if Nike regains retail partnerships; therefore deep-value long only makes sense only if NKE trades to >30% discount to peers on normalized 2027 EBITDA. The selloff may be overdone if China stimulus (consumption vouchers) triggers a quick rebound within 60–90 days — a risk to aggressive shorts. Historical parallels: companies (e.g., Adidas after China shocks) later recovered with three-year local strategies; Nike’s scale, innovation pipeline, and wholesale relationships make a multi-year reconstruction plausible but capital-intensive. Monitor China monthly retail figures and Nike’s China revenue guidance as 30–60 day decision points.

Key Decisions for Investors

• Establish a 3–5% notional short position in NKE equity or equivalently sized buy-to-open 6‑month put spread (10–15% OTM buy, 20–25% OTM sell) to express continued China headwinds; add 50% more notional only if NKE China sales decline another 10% sequentially or stock rises >12% from entry (stop-loss).
• Initiate a 2–3% long position in ANTA (or Li‑Ning ADRs/H‑shares) as a relative beneficiary of ‘guochao’ trends; scale to 4% if ANTA reports positive China footwear comparable sales or if NKE China comps miss by >5 p.p. on next earnings release.
• Implement a pair trade: long ANTA (2–3%) / short NKE (3–4%) to isolate China consumer-share rotation; rebalance if the pair diverges by >15% intrarelative performance or if ANTA margins compress >200 bps sequentially.
• If holding NKE long, buy 6‑month 10–15% OTM puts financed by selling 3‑month calls (covered if possible) to protect downside through the next two earnings; remove protection if Nike’s forward P/E falls to ≤25 with two consecutive quarters of China sequential improvement.
• Monitor three catalysts in next 30–90 days before scaling: monthly China retail sales (seek reversal to positive YoY), Nike China revenue guidance at next quarter, and any announced localization/JV — act (add/cover) within 7 trading days of catalyst confirmation.